Form 4: Ocular Therapeutix Chief Strategy Officer Sells Shares to Cover Tax Obligations

Ocular Therapeutix's Chief Strategy Officer, Sanjay Nayak, sold 1,814 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Sanjay Nayak, Chief Strategy Officer of Ocular Therapeutix, Inc., sold 1,814 shares of common stock on November 25, 2024.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units on November 22, 2024.
• The shares were sold at a weighted average price of $9, with individual transactions ranging from $8.88 to $9.10.
• The sale was not a discretionary trade but rather part of a pre-arranged automatic sale instruction adopted on February 21, 2024.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of any positive or negative sentiment regarding the company's performance.

Industry Context

This is a routine transaction for corporate officers who receive stock-based compensation. It is common for executives to sell shares to cover tax liabilities when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• Many companies use similar automatic sale plans to manage these transactions.
• The price range of $8.88 to $9.10 is within the typical range for such transactions.

Stakeholder Impact

• The sale has a minimal impact on shareholders as it is a routine transaction for tax purposes.

Key Dates

Keywords

Ocular Therapeutix, Sanjay Nayak, stock sale, insider trading, tax obligations, restricted stock units, automatic sale, Form 4